Diagnóstico no invasivo de amiloidosis cardiaca por transtirretina. Caso clínico
Povar Echeverria, M. ; Auquilla Clavijo, P.E. ; Escobedo Palau, J.A. (Universidad de Zaragoza) ; Navarro Beltran, P. ; Povar Marco, J.
Resumen: La amiloidosis cardiaca por transtirretina se considera en la actualidad la forma más frecuente de amiloidosis cardiaca y su incidencia está aumentando gracias al avance de las técnicas de diagnóstico por imagen. Recientemente se han publicado unos criterios de diagnóstico no invasivo para esta entidad, y se están desarrollando nuevos fármacos para el tratamiento específico de este tipo de amiloidosis cardiaca. Por ello, la amiloidosis cardiaca por transtirretina podría pasar de ser una enfermedad rara a frecuente, y de incurable a potencialmente tratable.
Presentamos el caso de un varón de 80 años diagnosticado de amiloidosis cardiaca mediante gammagrafía con 99mTc dicarboxipropano difosfonato (99mTc- DPD) según los nuevos criterios de diagnóstico no invasivo.
Amyloidosis due to deposits of transthyretin (ATTR) is currently considered the most frequent form of cardiac amyloidosis and its incidence is increasing thanks to the advances in diagnostic imaging techniques. Some non-invasive diagnostic criteria have recently been published on this entity that due to the development of new drugs for the specific treatment of cardiac ATTR, have prognostic and therapeutic implications. That is why cardiac ATTR could cease to be a rare disease and become a frequent one, and become potentially treatable instead of incurable. We present the case of an 80-year-old male diagnosed with non-hereditary cardiac ATTR by means of gammagraphy with 99mTc diphosfonate scintigraphy (99mTc-DPD) following the new criteria of non-invasive diagnosis.
Idioma: Español
DOI: 10.23938/ASSN.0295
Año: 2018
Publicado en: Anales del Sistema Sanitario De Navarra 41, 2 (2018), 263-267
ISSN: 1137-6627
Factor impacto JCR: 0.533 (2018)
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 158 / 162 = 0.975 (2018) - Q4 - T3
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 179 / 185 = 0.968 (2018) - Q4 - T3
Factor impacto SCIMAGO: 0.17 - Medicine (miscellaneous) (Q3)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2020-01-17-22:04:53)
Visitas y descargas
Presentamos el caso de un varón de 80 años diagnosticado de amiloidosis cardiaca mediante gammagrafía con 99mTc dicarboxipropano difosfonato (99mTc- DPD) según los nuevos criterios de diagnóstico no invasivo.
Amyloidosis due to deposits of transthyretin (ATTR) is currently considered the most frequent form of cardiac amyloidosis and its incidence is increasing thanks to the advances in diagnostic imaging techniques. Some non-invasive diagnostic criteria have recently been published on this entity that due to the development of new drugs for the specific treatment of cardiac ATTR, have prognostic and therapeutic implications. That is why cardiac ATTR could cease to be a rare disease and become a frequent one, and become potentially treatable instead of incurable. We present the case of an 80-year-old male diagnosed with non-hereditary cardiac ATTR by means of gammagraphy with 99mTc diphosfonate scintigraphy (99mTc-DPD) following the new criteria of non-invasive diagnosis.
Idioma: Español
DOI: 10.23938/ASSN.0295
Año: 2018
Publicado en: Anales del Sistema Sanitario De Navarra 41, 2 (2018), 263-267
ISSN: 1137-6627
Factor impacto JCR: 0.533 (2018)
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 158 / 162 = 0.975 (2018) - Q4 - T3
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 179 / 185 = 0.968 (2018) - Q4 - T3
Factor impacto SCIMAGO: 0.17 - Medicine (miscellaneous) (Q3)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2020-01-17-22:04:53)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
articulos
Notice créée le 2018-10-18, modifiée le 2020-01-17